학술논문
The Acquisition of Complement-Dependent Cytotoxicity by the Type II Anti-CD20 Therapeutic Antibody Obinutuzumab
Document Type
Article
Author
Source
In: Cancers . (Cancers, January 2024, 16(1))
Subject
Language
English
ISSN
20726694